|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency infection显示文摘 | Flexner C Barditch-Crovo PA Komhauser DM | 1991 | Antimicrob Agents Chemother1991，35，： | 1 |
| 2 | Drug inter-actions in patients infected with human immunodeficien-cy virus 显示文摘 | Piscitelli S C Flexner C Minor J R | 1996 | Clin Infect Dis1996，23，4： | 1 |
| 3 | Multiple-dose escalation study of the safety, pharmacokinetics, and bio- logic activity of oral AMD070, a selective CXCR4 recep-tor inhibitor, in human subjects 显示文摘 | Stone ND Dunaway SB Flexner C | 2007 | Antimicrob Agents Chemother2007，51，7： | 1 |
| 4 | Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers 显示文摘 | Hendrix C W Flexner C MacFarland R T | 2000 | Antimicrob Agents Chemother2000，44，6： | 1 |
| 5 | Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2显示文摘 | Flexner C Moss B London W T | 1990 | Vaccine1990，8，1： | 1 |
| 6 | Pharmacokinetics and safety of AMD3100, a novel antagonist of the CX-CR-4 chemokine receptor, in human volunteers显示文摘 | Hendrix CW Flexner C MacFarland RT | 2000 | Antimicrobial Agents Chemother2000，44，： | 1 |
| 7 | Relationship between plasma concentrations of 3'-deoxy-3'- fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials显示文摘 | Flexner C Van Der Horst C Jacobson MA | 1994 | J Infect Dis1994，170，6： | 1 |
| 8 | HIV Cure: Knocking on the Door显示文摘 | C M Durand C Flexner | 2013 | Clinical Pharmacology & Therapeutics2013，，5： | 1 |
| 9 | Pharmacokinetics toxicity,and activity of intravenous dextran sulfate in human immunodeficiency virus infection显示文摘 | Flexner C Barditch-Crovo PA Kornhauser DM | 1991 | Antimicrob Agents Chemother1991，35，12： | 1 |
| 10 | Pharmacology and drug interactions of HIV protease inhibitors显示文摘 | Flexner C W | 2002 | Infect Dis Ther2002，25，： | 1 |
| 11 | Prevention of vaccine virus in immunodeficient mice by vector directed IL-2 expression 显示文摘 | Flexner C Hugin A Moss B | 1987 | Nature1987，330，6145： | 1 |
| 12 | Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression显示文摘 | FLEXNER C HUGIN A MOSS B | 1987 | Nature1987，330，6145： | 1 |
| 13 | Prevention of vaccinia virus in immunodeficient mice by vector directed IL -2 expression显示文摘 | Flexner C Hugin A Moss B | 1987 | Nature1987，330，6145： | 1 |
| 14 | 查看详情显示文摘 | Flexner C | | 0，，： | 1 |
| 15 | Prevention of vaccinia virus infection in immunodeficient mice by vector directed IL-2 expression 显示文摘 | Flexner C A Hugin B Moss | 1987 | Nature1987，330，： | 1 |
| 16 | Prevention of vaccinia virus infection in immunodeficient mice by vector direction IL-2 expression显示文摘 | Flexner C Hugin A Moss B | 1987 | Nature1987，33，1： | 1 |
| 17 | Clearance of recombinant vaccinia virus expressing IL-2: role of local host immune responses 显示文摘 | Hugin W Flexner C Moss B | 1993 | Cell Immunol1993，152，2： | 1 |
| 18 | Prevention of vaccinia virus in immunodeficient mice by vector directed IL-2 expression显示文摘 | Flexner C Hugin A Moss B | 1987 | Nature1987，330，： | 1 |
| 19 | Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing study显示文摘 | CHEN JM FLEXNER C LIBERMAN RG | 2012 | Clin Sci2012，61，5： | 1 |
| 20 | HIV drug development: the next 25 years显示文摘 | Flexner C | 2007 | Nature Rev Drug Discov2007，6，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员